Skip to main content

Table 1 Cytostatic compounds used in the breast cancer spheroid model

From: Prospective cohort study using the breast cancer spheroid model as a predictor for response to neoadjuvant therapy – the SpheroNEO study

Name PPC conzentration [μg/ml] Literature source
Carboplatin 40.843 Go, Adjei, 1999 [53]
Cyclophosphamid 41.000 Egorin et al, 1989 [54]
Docetaxel 2.180 Baker et al, 2004 [55]; Bruno et al, 1998 [56]
Doxorubicin 1.640 Brana et al, 2014 [57]
Epirubicin 1.005 Reviewed in Fujimoto, 2007 [58]
Fluorouracil (5-FU) 100.000 Reviewed in Fujimoto, 2007 [58]
Paclitaxel 1.530 Gianni et al, 1995 [59]
Trastuzumab 88.000 Leyland-Jones, 2001 [60]